ARTICLE

SERUM LEVELS OF ERYTHROPOIETIN IN PATIENTS WITH ANEMIA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  1. HOME
  2. ARTICLE

05 Pages : 34-40

http://dx.doi.org/10.31703/gdddr.2023(VIII-II).05      10.31703/gdddr.2023(VIII-II).05      Published : Jun 2023

Serum Levels of Erythropoietin in Patients with Anemia and Chronic Obstructive Pulmonary Disease

Abstract

    Nanotechnology is the most common and frequently used technology that aims to improve the efficacy of medical procedures, sometimes known as Nanomedicine. With their impressive pharmacological efficacy as nanomedicines and delivery systems, nano materials have been recognized as attractive diagnostic and chemotherapeutic tools to treat diseases. To treat a wide range of solid malignant tumors, Drugs built on platinum complexes are now the foundation for many other therapies. They are often used to treat a variety of solid tumors in the clinic, including head and neck, colorectal, lung and other malignancies. Cell-specific targeting with nano-carriers is possible using both active and passive techniques. This paper provides a thorough overview of platinum-based drug delivery system with the help of nanotechnology. Their mechanisms of action used in the treatment of cancer and potential for further development are all anticipated.

    Nanomedicines, Platinum Drugs, Chemotherapeutic, Pharmacological drugs

    (1) Adam Fazli Rabbi
    Demonstrator, Department of Biochemistry, Rawal Institute of Health Sciences, Islamabad, Pakistan.
    (2) Malaika Khan
    Demonstrator, Department of Physiology, Rawal Institute of Health Sciences, Islamabad, Pakistan.
    (3) Maryam Shaid Ullah
    Department of Physiology, Khyber Medical University, Peshawar, KP, Pakistan.
    (4) Mohammad Israr
    Assistant Professor, Department of Biochemistry, Bacha Khan Medical College, Mardan, KP, Pakistan.
    (5) Somaya Noor
    Lecturer, Department of Physiology, Kabir Medical College, Gandhara University, Peshawar, KP, Pakistan.
    (6) Bibi Hajira Ishaq
    Assistant Professor, Department of Biochemistry, Khyber Medical College, Peshawar, KP, Pakistan.
Fulltext PDF

References

  • Ataran, D., Dalouei, M. K., Fereydoun, A., Talab, F. R., Mohammad, T., Amir, A. A., Babaeian, M., Saman, R., & Lari, S. H. M. (2009). ANEMIA IN COPD PATIENTS AND ITS RELATION TO SERUM LEVELS OF ERYTHROPOIETIN. Tanaffos: Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, 8(2), 11–16. http://www.mums.ac.ir/shares/ltrc/ltrc/paper/anemia%20in%20copd.pdf
  • Ble, A., Fink, J. C., Woodman, R. J., Klausner, M. A., Windham, B. G., Guralnik, J. M., & Ferrucci, L. (2005). Renal Function, Erythropoietin, and Anemia of Older Persons. Archives of Internal Medicine, 165(19), 2222. https://doi.org/10.1001/archinte.165.19.2222
  • Boutou, A. K., Karrar, S., Hopkinson, N. S., & Polkey, M. I. (2012). Anemia and Survival in Chronic Obstructive Pulmonary Disease: A Dichotomous rather than a Continuous Predictor. Respiration, 85(2), 126–131. https://doi.org/10.1159/000338792
  • Brugniaux, J. V., Schmitt, L., Robach, P., Nicolet, G., Fouillot, J., Moutereau, S., Lasne, F., Pialoux, V., Saas, P., Chorvot, M., Cornolo, J., Olsen, N. V., & Richalet, J. (2006). Eighteen days of “living high, training low” stimulate erythropoiesis and enhance aerobic performance in elite middle-distance runners. Journal of Applied Physiology, 100(1), 203–211. https://doi.org/10.1152/japplphysiol.00808.2005
  • DeAngelo, A. J., Bell, D., Quinn, M. A., Long, D., & Ouellette, D. R. (2005). Erythropoietin response in critically ill mechanically ventilated patients: a prospective observational study. Critical Care, 9(3), R172. https://doi.org/10.1186/cc3480
  • Gazzar, A. G. E., Mehy, G. F. A., Gouda, T. M., El-Shaer, O. S., & Mohammed, S. A. (2017). Evaluation of erythropoietin hormone in chronic obstructive pulmonary disease patients during exacerbation and after remission. Egyptian Journal of Chest Diseases and Tuberculosis. https://doi.org/10.1016/j.ejcdt.2016.08.015
  • Elkorashy, R. I., Amin, Y. M., Moussa, H. A., Badawy, I., & Bakr, S. (2012). Study the relationship of erythropoietin and chronic obstructive pulmonary disease. Egyptian Journal of Chest Diseases and Tuberculosis, 61(3), 53–57. https://doi.org/10.1016/j.ejcdt.2012.10.026
  • Hobisch-Hagen, P., Wiedermann, F. J., Mayr, A., Fries, D., Jelkmann, W., Fuchs, D., Hasibeder, W. R., Mutz, N., Klingler, A., & Schobersberger, W. (2001). Blunted erythropoietic response to anemia in multiply traumatized patients. Critical Care Medicine, 29(4), 743–747. https://doi.org/10.1097/00003246-200104000-00009
  • Incalzi, R. A., Corsonello, A., Pedone, C., Battaglia, S., Paglino, G., & Bellia, V. (2010). Chronic Renal Failure. Chest, 137(4), 831– 837. https://doi.org/10.1378/chest.09-1710
  • John, M., Hoernig, S., Doehner, W., Okonko, D. O., Witt, C., & Anker, S. D. (2005). Anemia and Inflammation in COPD. Chest, 127(3), 825–829. https://doi.org/10.1378/chest.127.3.825
  • Mannino, D. M., & Kiri, V. A. (2006). Changing the burden of COPD mortality. International Journal of Chronic Obstructive Pulmonary Disease, 1(3), 219–233. https://doi.org/10.2147/copd.2006.1.3.219
  • Marti, H. (2004). Erythropoietin and the hypoxic brain. The Journal of Experimental Biology, 207(18), 3233–3242. https://doi.org/10.1242/jeb.01049
  • PÅ‚oszczyca, K., Langfort, J., & Czuba, M. (2018). The Effects of Altitude Training on Erythropoietic Response and Hematological Variables in Adult Athletes: A Narrative Review. Frontiers in Physiology, 9. https://doi.org/10.3389/fphys.2018.00375
  • Portillo, K., Martínez-Rivera, C., & Ruiz- Manzano, J. (2013). Anaemia in chronic obstructive pulmonary disease. Does it really matter? International Journal of Clinical Practice, 67(6), 558–565. https://doi.org/10.1111/ijcp.12125
  • Ryu, J. H., & Scanlon, P. D. (2001). Obstructive Lung Diseases: COPD, Asthma, and Many Imitators. Mayo Clinic Proceedings, 76(11), 1144–1153. https://doi.org/10.4065/76.11.1144
  • Sala, E., Balaguer, C., Villena, C., Ríos, Á., Noguera, A., Núñez, B., & Agusti, A. (2010). Low Erythropoietin Plasma Levels during Exacerbations of COPD. Respiration, 80(3), 190–197. https://doi.org/10.1159/000264604
  • Sharma, R., & Chakrabarti, S. (2016). Anaemia secondary to erythropoietin resistance: important predictor of adverse outcomes in chronic obstructive pulmonary disease. Postgraduate Medical Journal, 92(1093), 636–639. https://doi.org/10.1136/postgradmedj-2015-133814
  • Shorr, A. F., Doyle, J., Stern, L., Dolgitser, M., & Zilberberg, M. D. (2008). Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Current Medical Research and Opinion, 24(4), 1123–1130. https://doi.org/10.1185/030079908x280699
  • Tassiopoulos, S., Kontos, A., Konstantopoulos, K., Hadzistavrou, C., Vaiopoulos, G., Aessopos, A., & Tassiopoulos, T. (2001). Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease. Respiratory Medicine, 95(6), 471– 475. https://doi.org/10.1053/rmed.2001.1070
  • Vanasse, G. J., & Berliner, N. (2010). Anemia in Elderly Patients: An Emerging Problem for the 21st Century. Hematology, 2010(1), 271– 275. https://doi.org/10.1182/asheducation-2010.1.271

Cite this article

APA

    APA : Rabbi, A. F., Khan, M., & Ullah, M. S. (2023). Serum Levels of Erythropoietin in Patients with Anemia and Chronic Obstructive Pulmonary Disease. Global Drug Design & Development Review, VIII(II), 34-40. https://doi.org/10.31703/gdddr.2023(VIII-II).05

CHICAGO

    CHICAGO : Rabbi, Adam Fazli, Malaika Khan, and Maryam Shaid Ullah. 2023. "Serum Levels of Erythropoietin in Patients with Anemia and Chronic Obstructive Pulmonary Disease." Global Drug Design & Development Review, VIII (II): 34-40 doi: 10.31703/gdddr.2023(VIII-II).05

HARVARD

    HARVARD : RABBI, A. F., KHAN, M. & ULLAH, M. S. 2023. Serum Levels of Erythropoietin in Patients with Anemia and Chronic Obstructive Pulmonary Disease. Global Drug Design & Development Review, VIII, 34-40.

MHRA

    MHRA : Rabbi, Adam Fazli, Malaika Khan, and Maryam Shaid Ullah. 2023. "Serum Levels of Erythropoietin in Patients with Anemia and Chronic Obstructive Pulmonary Disease." Global Drug Design & Development Review, VIII: 34-40

MLA

    MLA : Rabbi, Adam Fazli, Malaika Khan, and Maryam Shaid Ullah. "Serum Levels of Erythropoietin in Patients with Anemia and Chronic Obstructive Pulmonary Disease." Global Drug Design & Development Review, VIII.II (2023): 34-40 Print.

OXFORD

    OXFORD : Rabbi, Adam Fazli, Khan, Malaika, and Ullah, Maryam Shaid (2023), "Serum Levels of Erythropoietin in Patients with Anemia and Chronic Obstructive Pulmonary Disease", Global Drug Design & Development Review, VIII (II), 34-40

TURABIAN

    TURABIAN : Rabbi, Adam Fazli, Malaika Khan, and Maryam Shaid Ullah. "Serum Levels of Erythropoietin in Patients with Anemia and Chronic Obstructive Pulmonary Disease." Global Drug Design & Development Review VIII, no. II (2023): 34-40. https://doi.org/10.31703/gdddr.2023(VIII-II).05